Page last updated: 2024-08-17

carbostyril and Thrombopenia

carbostyril has been researched along with Thrombopenia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Asai, K; Hino, M; Hirose, A; Imoto, W; Kakeya, H; Kaneko, Y; Kawaguchi, T; Koh, H; Nakaie, K; Nakamae, H; Namikawa, H; Shibata, W; Watanabe, T; Yamada, K; Yamairi, K; Yoshii, N; Yukawa, S1
Lesur, O; Pilon, D; Tétrault, JP; Williamson, DR1
Andrade, C; Duggal, H; Mendhekar, D1
Dowsett, M; Ellis, P; Hickish, T; Houston, S; Howes, A; Johnston, SR; Kelland, L; Michiels, B; Palmer, P; Perez-Ruixo, JJ; Salter, J1
Norman, P1

Reviews

1 review(s) available for carbostyril and Thrombopenia

ArticleYear
Tipifarnib (Janssen Pharmaceutica).
    Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:2

    Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Ataxia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drugs, Investigational; Farnesyltranstransferase; Humans; Neoplasms; Quinolones; Structure-Activity Relationship; Thrombocytopenia; Treatment Outcome

2002

Trials

1 trial(s) available for carbostyril and Thrombopenia

ArticleYear
Phase II study of the efficacy and tolerability of two dosing regimens of the farnesyl transferase inhibitor, R115777, in advanced breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jul-01, Volume: 21, Issue:13

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Neoplasm Metastasis; Neutropenia; Quinolones; Thrombocytopenia; Treatment Outcome

2003

Other Studies

3 other study(ies) available for carbostyril and Thrombopenia

ArticleYear
Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
    Internal medicine (Tokyo, Japan), 2020, Volume: 59, Issue:2

    Topics: Adult; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hemoptysis; Hemorrhage; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Prognosis; Quinolones; Retrospective Studies; Risk Factors; Stenotrophomonas maltophilia; Thrombocytopenia; Trimethoprim, Sulfamethoxazole Drug Combination

2020
Drug-induced thrombocytopenia in the critically ill: a case-control study.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:6

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Case-Control Studies; Critical Illness; Female; Heparin; Humans; Intensive Care Units; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Quebec; Quinolones; Risk Factors; Thrombocytopenia

2014
Leukopenia and thrombocytopenia on adding aripiprazole to phenytoin.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:4 Pt 3

    Topics: Adult; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Leukopenia; Phenytoin; Piperazines; Quinolones; Schizophrenia, Paranoid; Thrombocytopenia

2009